Former Executive Vice President and Chief Strategy & Growth Officer · Pediatrix Medical Group, Inc. (MD)

Nicholas Nikolopoulos

FY2020 is the first fiscal year CompBrief holds for Nicholas Nikolopoulos as a named executive officer of Pediatrix Medical; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$2,580,427

Salary $431,250Stock awards $1,300,008

6th of 8 named executive officers at Pediatrix Medical by FY2020 total.

8 named officers on file for Pediatrix Medical, FY2020

Nicholas Nikolopoulos’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • MD’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Pediatrix Medical’s whole pay program stands against its peers

  • Pediatrix Medical’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 23, 2021 (DEF 14A).

Free

Get Nicholas Nikolopoulos’s full pay file as a PDF — free

More than this page: up to 10 years of Nicholas’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Nicholas Nikolopoulos compensation by year

Pediatrix Medical Summary Compensation Table · the one fiscal year held
In US dollars, as Pediatrix Medical reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$431,250
Bonus$0
Stock awards$1,300,008
Option awards$0
Non-equity incentive$500,000
Pension and deferred compensation$0
All other$349,169
Total$2,580,427

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Pediatrix Medical Group, Inc. DEF 14A filed March 23, 2021, accession 0001193125-21-091206, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Pediatrix Medical Group, Inc. filed document, accession 0001193125-21-091206. Every figure is read from that document and cited to the page and table it appears in. Filed March 23, 2021.

Pediatrix Medical’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Roger MedelFormer Chief Executive Officer$7,597,254
Stephen FarberFormer Executive Vice President and Chief Financial Officer$7,043,175
Mark OrdanChief Executive Officer$6,438,682
Dominic AndreanoExecutive Vice President, General Counsel and Secretary$3,376,947
Roger HinsonPresident, Pediatrix and Obstetrix Medical Group$2,913,219
Nicholas Nikolopoulos · this pageFormer Executive Vice President and Chief Strategy & Growth Officer$2,580,427
C. Marc RichardsExecutive Vice President and Chief Financial Officer$1,967,008
John PepiaSenior Vice President and Chief Accounting Officer$1,299,406

The full Pediatrix Medical compensation record

free company brief

This page is one person within Pediatrix Medical's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Pediatrix Medical proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Pediatrix Medical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Nicholas Nikolopoulos's compensation dossier · One-time report. No refunds.